GBA1 and Parkinson disease: Our study provides evidence that TFEB dysfunction might be mediated by pathogenic lipid accumulation in GBA1-associated PD and points to the potential therapeutic benefits of targeting mTORC1-TFEB axis on ameliorating the neurodegenerative process.